Xiao-Yan He Selected Research

AGRO 100

10/2023	A Multifunctional Delivery System for Remodulating Cell Behaviors of Circulating Malignant Cells to Prevent Cell Fusion.
4/2020	Aptamer/Peptide-Functionalized Genome-Editing System for Effective Immune Restoration through Reversal of PD-L1-Mediated Cancer Immunosuppression.
1/2020	Facile Strategy To Enhance Specificity and Sensitivity of Molecular Beacons by an Aptamer-Functionalized Delivery Vector.
7/2019	Peptide and Aptamer Decorated Delivery System for Targeting Delivery of Cas9/sgRNA Plasmid To Mediate Antitumor Genome Editing.
12/2018	Tumor targeted genome editing mediated by a multi-functional gene vector for regulating cell behaviors.
12/2018	Reversal of tumor malignization and modulation of cell behaviors through genome editing mediated by a multi-functional nanovector.
11/2018	Aptamer-functionalized albumin-based nanoparticles for targeted drug delivery.
1/2018	A Dual-Targeting Delivery System for Effective Genome Editing and In Situ Detecting Related Protein Expression in Edited Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao-Yan He Research Topics

Disease

30	Neoplasms (Cancer) 10/2023 - 07/2010
6	Circulating Neoplastic Cells 10/2023 - 10/2021
6	Neoplasm Metastasis (Metastasis) 12/2021 - 11/2018
5	Schizophrenia (Dementia Praecox) 03/2023 - 01/2019
5	Infections 01/2023 - 06/2004
5	COVID-19 01/2023 - 01/2021
5	Inflammation (Inflammations) 02/2022 - 05/2013
4	Hypoxia (Hypoxemia) 10/2023 - 01/2020
4	Psychotic Disorders (Schizoaffective Disorder) 08/2023 - 01/2019
4	Ischemia 11/2022 - 01/2020
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022 - 01/2022
2	Pneumonia (Pneumonitis) 12/2021 - 09/2021
2	Carcinoma (Carcinomatosis) 06/2021 - 07/2010
2	Carcinogenesis 06/2021 - 06/2017
2	Silicosis 01/2021 - 01/2021
2	Fibrosis (Cirrhosis) 01/2021 - 04/2015
2	Aneurysm (Aneurysms) 08/2016 - 01/2015
1	HIV Infections (HIV Infection) 05/2024
1	Acute Kidney Injury (Acute Renal Failure) 10/2023
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023
1	Leukopenia 01/2023
1	Thrombocytopenia (Thrombopenia) 01/2023
1	Fever (Fevers) 01/2023
1	Persistent Infection 07/2022
1	Pancreatitis 05/2022
1	Leukemia 01/2022
1	Immune System Diseases (Immune Disorders) 01/2022

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2004
8	Peptides (Polypeptides)IBA 10/2023 - 06/2004
8	AGRO 100IBA 10/2023 - 01/2018
7	Hyaluronic Acid (Hyaluronan)IBA 10/2023 - 08/2018
5	MicroRNAs (MicroRNA)IBA 10/2023 - 07/2010
5	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2022
5	Messenger RNA (mRNA)IBA 10/2023 - 04/2010
4	Cisplatin (Platino)FDA LinkGeneric 10/2023 - 01/2022
4	Cadherins (E-Cadherin)IBA 01/2022 - 11/2018
4	LigandsIBA 06/2021 - 07/2015
4	NucleolinIBA 11/2020 - 12/2018
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2019 - 01/2018
4	VimentinIBA 07/2019 - 11/2018
3	Clozapine (Clozaril)FDA LinkGeneric 03/2023 - 01/2022
3	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2022
3	Histones (Histone)IBA 01/2023 - 11/2020
3	Polytetrafluoroethylene (Teflon)FDA Link 01/2023 - 01/2019
3	InterferonsIBA 01/2023 - 01/2021
3	CytokinesIBA 01/2023 - 02/2014
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2021
3	Therapeutic UsesIBA 01/2021 - 09/2018
3	Protamines (Protamine Sulfate)FDA Link 01/2020 - 01/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2019 - 01/2017
3	OligodeoxyribonucleotidesIBA 03/2019 - 12/2017
3	AlbuminsIBA 01/2019 - 07/2015
3	PolymersIBA 12/2018 - 01/2017
3	Biotin (Vitamin H)FDA Link 01/2018 - 01/2017
2	Tumor Biomarkers (Tumor Markers)IBA 10/2023 - 01/2023
2	ErbB Receptors (EGF Receptor)IBA 10/2023 - 01/2023
2	Phosphotransferases (Kinase)IBA 10/2023 - 06/2017
2	Mucin-1 (CA 15-3 Antigen)IBA 01/2023 - 12/2018
2	Epithelial Cell Adhesion MoleculeIBA 01/2023 - 11/2018
2	DNA (Deoxyribonucleic Acid)IBA 07/2022 - 08/2018
2	Chemokine ReceptorsIBA 01/2022 - 01/2021
2	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 01/2022
2	Antihypertensive Agents (Antihypertensives)IBA 09/2021 - 04/2015
2	Glucose (Dextrose)FDA LinkGeneric 06/2021 - 01/2020
2	Angiotensin-Converting Enzyme 2IBA 01/2021 - 04/2010
2	ParaffinIBA 01/2021 - 06/2017
2	Formaldehyde (Formol)FDA Link 01/2021 - 06/2017
2	Analgesics (Analgesic Drugs)IBA 05/2020 - 04/2015
2	Blood Glucose (Blood Sugar)IBA 05/2020 - 04/2015
2	CateninsIBA 04/2020 - 01/2019
2	carboxymethyl-chitosanIBA 01/2020 - 06/2017
2	SurvivinIBA 01/2020 - 01/2018
2	Matrix Metalloproteinases (MMPs)IBA 07/2019 - 12/2018
2	Focal Adhesion Protein-Tyrosine KinasesIBA 07/2019 - 12/2018
2	CaspasesIBA 01/2019 - 12/2017
2	micaIBA 12/2018 - 12/2018
2	CalreticulinIBA 01/2017 - 02/2014
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 10/2023
1	Protein Kinases (Protein Kinase)IBA 10/2023
1	mesoglycanIBA 08/2023
1	SARS-CoV-2 envelope proteinIBA 01/2023
1	pembrolizumabIBA 01/2023
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2023
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 01/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023
1	Bevacizumab (Avastin)FDA Link 01/2023
1	VaccinesIBA 01/2023
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 12/2022
1	2,2,2- trifluoro- N- (1- ((1- (4- fluorophenyl)- 1H- indazol- 5- yl)oxy)- 1- (3- methoxyphenyl)- 2- propanyl)acetamideIBA 11/2022
1	GSK872IBA 11/2022
1	Viral RNAIBA 07/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2022
1	LipopolysaccharidesIBA 01/2022
1	ribosomal protein L15IBA 01/2022
1	HomocysteineIBA 01/2022
1	6-methyladenineIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022

Therapy/Procedure

10	Therapeutics 05/2024 - 10/2015
2	Drug Therapy (Chemotherapy) 01/2023 - 01/2017
2	Immunotherapy 01/2019 - 08/2018